SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation
Abstract Background SETD2 is the sole epigenetic factor responsible for catalyzing histone 3, lysine 36, tri-methylation (H3K36me3) in mammals. Its role in regulating cellular processes such as RNA splicing, DNA repair, and spurious transcription initiation underlies its broader tumor suppressor fun...
Saved in:
Main Authors: | Ryan T. Wagner, Ryan A. Hlady, Xiaoyu Pan, Liguo Wang, Sungho Kim, Xia Zhao, Louis Y. El Khoury, Shafiq Shaikh, Jian Zhong, Jeong-Heon Lee, Jolanta Grembecka, Tomasz Cierpicki, Thai H. Ho, Keith D. Robertson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Genome Biology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13059-025-03483-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AURKB affects the proliferation of clear cell renal cell carcinoma by regulating fatty acid metabolism
by: Yang Yang, et al.
Published: (2025-01-01) -
Overexpression of PLCG2 and TMEM38A inhibit tumor progression in clear cell renal cell carcinoma
by: Yiqiao Zhao, et al.
Published: (2025-01-01) -
Editörden
by: Tolga Çakmak
Published: (2022-09-01) -
Analysis of the efficacy of multidisciplinary integration based on 3D reconstruction technology for the treatment of gout stone
by: Shizhe Zhou, et al.
Published: (2025-02-01) -
Human Serum Albumin and Human Serum Albumin Nanoparticles as Carriers of 10-(2′-Pyrimidyl)-3,6-diazaphenothiazine: In Vitro Spectroscopic Studies
by: Aleksandra Owczarzy, et al.
Published: (2025-01-01)